Augmented Reality–Guided Decision Support in Simulated Pediatric Cardiac Arrest: A Randomized Clinical Trial - Scorecard - MDSpire

Augmented Reality–Guided Decision Support in Simulated Pediatric Cardiac Arrest: A Randomized Clinical Trial

  • By

  • Johan N. Siebert

  • Adam Cheng

  • Alexandre De Masi

  • Ana Rajic

  • Sharleen K. Olanka

  • Marco Generelli

  • Jennifer Davidson

  • Ryan Kang

  • Kangsoo Kim

  • Pierre-Louis Rebours

  • Marc Ibrahim

  • Donovan Duncan

  • Isabelle Jordan

  • Frédéric Ehrler

  • Delphine S. Courvoisier

  • Yiqun Lin

  • Sergio Manzano

  • May 22, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing Augmented Reality for Enhanced Decision Support During Simulated Pediatric Cardiac Arrest: Results from a Randomized Clinical Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPediatric patients (ages 0-18) experiencing cardiac arrest.
Care Setting

Key Highlights

  • Study shows significant improvement in team coordination and situational awareness.

Guideline-Based Recommendations

Diagnosis

    Management

    • Adherence to AHA PALS guidelines during resuscitation (specific guidelines to be listed).

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Use of augmented reality to guide medication administration and adherence to resuscitation protocols, enhancing accuracy and reducing errors.

        Clinical Best Practices

        • Strict adherence to AHA PALS guidelines.
        • Utilization of cognitive aids to improve guideline compliance, supported by evidence from recent studies.
        • Team-level coordination during resuscitation efforts.

        Related Resources & Content

        Original Source(s)

        Augmented Reality–Guided Decision Support in Simulated Pediatric Cardiac Arrest: A Randomized Clinical Trial

        • by Johan N. Siebert, Adam Cheng, Alexandre De Masi, Ana Rajic, Sharleen K. Olanka, Marco Generelli, Jennifer Davidson, Ryan Kang, Kangsoo Kim, Pierre-Louis Rebours, Marc Ibrahim, Donovan Duncan, Isabelle Jordan, Frédéric Ehrler, Delphine S. Courvoisier, Yiqun Lin, Sergio Manzano

        • May 22, 2026

        Related Content

        Perampanel use in pediatric autoimmune encephalitis-related seizures and epilepsy: a retrospective case series

        Ensitrelvir Reduced COVID After Household Exposure

        In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

        Comparative evaluation of SBS and RASS for sedation assessment in mechanically ventilated children